Article
Multidisciplinary Sciences
William H. Hoffman, Stephen A. Whelan, Norman Lee
Summary: Diabetic ketoacidosis (DKA) is a serious complication of Type 1 diabetes (T1D) caused by insulin deficiency and insulin resistance. The metabolic and immunologic dysregulation in DKA leads to oxidative stress, inflammation, and the development of brain edema (BE). Changes in the tryptophan (TRP)/kynurenine pathway (KP) metabolites may play a role in the pathogenesis of DKA/BE.
Article
Endocrinology & Metabolism
Nicole K. Gibbings, Paul A. Kurdyak, Patricia A. Colton, Baiju R. Shah
Summary: Adolescents and young adults with type 1 diabetes and eating disorders have more than triple the risk of DKA and nearly sixfold increased risk of death compared with their peers without eating disorders.
Article
Endocrinology & Metabolism
Elizabeth S. Keiner, James C. Slaughter, Karishma A. Datye, Alan D. Cherrington, Daniel J. Moore, Justin M. Gregory
Summary: COVID-19 infection in pediatric patients with type 1 diabetes is associated with lower tissue glucose disposal during standardized therapy for diabetic ketoacidosis (DKA), suggesting a metabolic derangement caused by COVID-19.
Article
Endocrinology & Metabolism
Charlotte Loh, Paul Weihe, Nicole Kuplin, Kerstin Placzek, Susann Weihrauch-Blueher
Summary: The study analyzed the impact of the COVID-19 lockdown on children with diabetes mellitus, showing that the lockdown resulted in younger age and more severe DKA symptoms in children with new-onset diabetes, leading to longer hospital stays.
METABOLISM-CLINICAL AND EXPERIMENTAL
(2021)
Article
Pediatrics
Clemens Kamrath, Joachim Rosenbauer, Alexander J. Eckert, Angeliki Pappa, Felix Reschke, Tilman R. Rohrer, Kirsten Moenkemoeller, Michael Wurm, Kathrin Hake, Klemens Raile, Reinhard W. Holl
Summary: This study aimed to quantify the relative risk of diabetic ketoacidosis in children with newly diagnosed type 1 diabetes in 2020 and examine its association with regional COVID-19 incidence. The findings indicate a significant increase in ketoacidosis frequency compared to expected rates during certain months in 2020, with a positive association between regional COVID-19 incidence and ketoacidosis risk in the first half of the year. However, this association was not observed in the second half of 2020.
Article
Endocrinology & Metabolism
Angela Ibald-Mulli, Jochen Seufert, Julia M. Grimsmann, Markus Laimer, Peter Bramlage, Alexandre Civet, Margot Blanchon, Simon Gosset, Alexandre Templier, W. Dieter Paar, Fang Liz Zhou, Stefanie Lanzinger
Summary: This study aimed to identify predictive factors for diabetic ketoacidosis (DKA) by analyzing registry data and using a subgroup discovery algorithm. The findings showed several clinical characteristics associated with an increased risk of DKA, including low body mass index standard deviation score, DKA at diagnosis, specific age groups, higher HbA1c levels, no fast-acting insulin intake, certain age groups not using a continuous glucose monitoring system, physician diagnosis of nephrotic kidney disease, severe hypoglycemia, hypoglycemic coma, and autoimmune thyroiditis. The risk of DKA increased with the number of risk profiles matching the patients' characteristics.
DIABETES OBESITY & METABOLISM
(2023)
Article
Multidisciplinary Sciences
Aila J. Ahola, Valma Harjutsalo, Merlin C. Thomas, Carol Forsblom, Per-Henrik Groop
Summary: The study investigated the relationship between diet and hospitalization risk for DKA or hypoglycemia in type 1 diabetes patients. Alcohol intake was associated with increased risk of DKA hospitalization, while higher fiber intake seemed to be protective. Substituting carbohydrates for fats increased the risk of hypoglycemia hospitalization.
SCIENTIFIC REPORTS
(2021)
Article
Medicine, General & Internal
Hugo Segerer, Michael Wurm, Julia M. Grimsmann, Beate Karges, Andreas Neu, Marina Sindichakis, Katharina Warncke, Axel Dost, Reinhard W. Holl
Summary: The study found that the incidence of DKA at the time of T1D diagnosis in children and adolescents did not decrease between 2000 and 2019. Patients with MiH, children under 6, and girls were at a higher risk of DKA.
DEUTSCHES ARZTEBLATT INTERNATIONAL
(2021)
Article
Endocrinology & Metabolism
Halis Kaan Akturk, Janet Snell-Bergeon, Gregory L. Kinney, Anagha Champakanath, Andrew Monte, Viral N. Shah
Summary: The study found that cannabis users had significantly higher pH and bicarbonate levels compared to non-users, and the accuracy of predicting HK-CHS with a positive cannabis urine test result was high.
Article
Endocrinology & Metabolism
Guy Todd Alonso, Osagie Ebekozien, Mary Pat Gallagher, Saketh Rompicherla, Sarah K. Lyons, Abha Choudhary, Shideh Majidi, Catherina T. Pinnaro, Sadana Balachandar, Mariam Gangat, Alissa Jeanne Curda Roberts, Brynn E. Marks, Ana Creo, Janine Sanchez, Tossaporn Seeherunvong, Jose Jimenez-Vega, Neha S. Patel, Jamie R. Wood, Liana Gabriel, Kathryn M. Sumpter, Meredith Wilkes, Robert Rapaport, Anna Cymbaluk, Jenise C. Wong, Srinath Sanda, Anastasia Albanese-O'neill
Summary: Analysis of data from pediatric patients under 19 years old with type 1 diabetes and COVID-19 found that higher A1c levels were the only predictor for hospitalization, with diabetic ketoacidosis being the primary concern in this group.
JOURNAL OF DIABETES
(2021)
Article
Endocrinology & Metabolism
Halis Kaan Akturk, Janet Snell-Bergeon, Gregory L. Kinney, Anagha Champakanath, Andrew Monte, Viral N. Shah
Summary: The study aimed to differentiate between diabetic ketoacidosis (DKA) and hyperglycemic ketosis due to cannabis hyperemesis syndrome (HK-CHS) in adults with type 1 diabetes. It was found that cannabis users had higher levels of pH and bicarbonate compared to non-users. A positive urine test result for cannabis could be used to predict the occurrence of HK-CHS.
Article
Cardiac & Cardiovascular Systems
Huan Chen, Yochai Birnbaum, Regina Ye, Hsiu-Chiung Yang, Mandeep Bajaj, Yumei Ye
Summary: SGLT2 inhibitors increase plasma ketone concentrations and may induce ketoacidosis in diabetes patients. Dehydration can precipitate SGLT2 inhibitor-induced ketoacidosis in type-2 diabetes. Dapagliflozin attenuated the development of ketoacidosis and associated signaling pathways in T1DM mice.
CARDIOVASCULAR DRUGS AND THERAPY
(2022)
Article
Endocrinology & Metabolism
Hafeez Shaka, Maria Aguilera, Maria Aucar, Zain El-Amir, Farah Wani, Chukwudi Charles Muojieje, Asim Kichloo
Summary: This study analyzed the 2018 Nationwide Readmission Database to describe rates and characteristics of nonelective 30-day readmission among adult patients with T1DM hospitalized for DKA, as well as identify predictors of readmission. The study found a high readmission rate for DKA in T1DM patients, with most patients having DKA as the principal diagnosis on readmission. Predictors of readmission included a Charlson Comorbidity Index (CCI) score of 3 or greater, hypertension, female sex, and being discharged against medical advice.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
(2021)
Article
Cell Biology
Blake E. Nichols, Jessica S. Hook, Kayson Weng, Chul Ahn, Jessica G. Moreland
Summary: A study found a unique primed phenotype in circulating leukocytes of T1D patients, regardless of DKA status. This phenotype is associated with a hyperinflammatory state and may be linked to a single nucleotide polymorphism in the TLR-1 gene.
JOURNAL OF LEUKOCYTE BIOLOGY
(2022)
Article
Endocrinology & Metabolism
Hafeez Shaka, Maria Aguilera, Maria Aucar, Zain El-Amir, Farah Wani, Chukwudi Charles Muojieje, Asim Kichloo
Summary: This study found a high 30-day readmission rate for patients with Type 1 diabetes hospitalized for DKA, with female sex, a Charlson Comorbidity Index of 3 or greater, and discharge against medical advice being significant predictors of readmission.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
(2021)